The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AKERO THERAPEUTICS INC | COM | 00973Y108 | 45,931 | 2,171,664 | SH | SOLE | 2,171,664 | 0 | 0 | ||
ALX ONCOLOGY HLDGS INC | COM | 00166B105 | 208,451 | 9,699,925 | SH | SOLE | 9,699,925 | 0 | 0 | ||
CHECKMATE PHARMACEUTICALS IN | COM | 162818108 | 10,543 | 3,673,374 | SH | SOLE | 3,673,374 | 0 | 0 | ||
ELEVATION ONCOLOGY INC | COM | 28623U101 | 15,701 | 2,608,167 | SH | SOLE | 2,608,167 | 0 | 0 | ||
HARMONY BIOSCIENCES HLDGS IN | COM | 413197104 | 116,851 | 2,740,411 | SH | SOLE | 2,740,411 | 0 | 0 | ||
IMPEL NEUROPHARMA INC | COM | 45258K109 | 23,817 | 2,759,791 | SH | SOLE | 2,759,791 | 0 | 0 | ||
PHARVARIS N V | COM | N69605108 | 33,145 | 2,303,310 | SH | SOLE | 2,303,310 | 0 | 0 | ||
VENTYX BIOSCIENCES INC | COM | 92332V107 | 99,529 | 5,011,536 | SH | SOLE | 5,011,536 | 0 | 0 | ||
VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 1,088 | 161,897 | SH | SOLE | 161,897 | 0 | 0 |